 | • レポートコード：B-GIR08C2508 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ゲフィチニブの世界市場について調べ、まとめました。種類別セグメントは、10テーブル/箱、30テーブル/箱、90テーブル/箱等、用途別セグメントは、業務用、政府用、個人用、その他等に区分しました。ゲフィチニブの世界市場概観、企業動向、企業別ゲフィチニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ゲフィチニブの市場概観 ・ゲフィチニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ゲフィチニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ゲフィチニブの世界市場規模 ・ゲフィチニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ゲフィチニブのアメリカ市場規模推移 ・ゲフィチニブのカナダ市場規模推移 ・ゲフィチニブのメキシコ市場規模推移 ・ゲフィチニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ゲフィチニブのドイツ市場規模推移 ・ゲフィチニブのイギリス市場規模推移 ・ゲフィチニブのロシア市場規模推移 ・ゲフィチニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ゲフィチニブの日本市場規模推移 ・ゲフィチニブの中国市場規模推移 ・ゲフィチニブの韓国市場規模推移 ・ゲフィチニブのインド市場規模推移 ・ゲフィチニブの東南アジア市場規模推移 ・ゲフィチニブの南米市場分析（ブラジル、アルゼンチン等） ・ゲフィチニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ゲフィチニブの種類別分析/販売量、売上、市場シェア（10テーブル/箱、30テーブル/箱、90テーブル/箱） ・ゲフィチニブの用途別分析/市場規模（業務用、政府用、個人用、その他） ・ゲフィチニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ゲフィチニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Gefitinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Gefitinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca
Qilu Pharmaceutical
Natco Pharma
Celon Laboratories
Hetero Drugs
Dr Reddy’s Laboratories
Zuventus Healthcare
United Biotech
Panacea Biotec
Cipla
Glenmark Pharmaceuticals
Nobel Ilac Sanayii Ve Ticaret
Accure Labs
Cadila Pharmaceuticals
Ethypharm
Flagship Biotech International
Globela Pharma
Jodas Expoim
Nishchay Pharmaceuticals
Sichuan Xieli Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
10 Tables/Box
30 Tables/Box
90 Tables/Box
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gefitinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gefitinib, with price, sales, revenue and global market share of Gefitinib in 2017 and 2018.
Chapter 3, the Gefitinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gefitinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Gefitinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Gefitinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gefitinib Introduction
1.2 Market Analysis by Type
1.2.1 10 Tables/Box
1.2.2 30 Tables/Box
1.2.3 90 Tables/Box
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Gefitinib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Qilu Pharmaceutical
2.2.1 Business Overview
2.2.2 Gefitinib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Qilu Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Natco Pharma
2.3.1 Business Overview
2.3.2 Gefitinib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Natco Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Celon Laboratories
2.4.1 Business Overview
2.4.2 Gefitinib Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celon Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hetero Drugs
2.5.1 Business Overview
2.5.2 Gefitinib Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hetero Drugs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dr Reddy’s Laboratories
2.6.1 Business Overview
2.6.2 Gefitinib Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr Reddy’s Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Zuventus Healthcare
2.7.1 Business Overview
2.7.2 Gefitinib Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Zuventus Healthcare Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 United Biotech
2.8.1 Business Overview
2.8.2 Gefitinib Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 United Biotech Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Panacea Biotec
2.9.1 Business Overview
2.9.2 Gefitinib Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Panacea Biotec Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Cipla
2.10.1 Business Overview
2.10.2 Gefitinib Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cipla Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Glenmark Pharmaceuticals
2.11.1 Business Overview
2.11.2 Gefitinib Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Glenmark Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Nobel Ilac Sanayii Ve Ticaret
2.12.1 Business Overview
2.12.2 Gefitinib Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Accure Labs
2.13.1 Business Overview
2.13.2 Gefitinib Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Accure Labs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Cadila Pharmaceuticals
2.14.1 Business Overview
2.14.2 Gefitinib Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Cadila Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.15 Ethypharm
2.15.1 Business Overview
2.15.2 Gefitinib Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Ethypharm Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.16 Flagship Biotech International
2.16.1 Business Overview
2.16.2 Gefitinib Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Flagship Biotech International Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.17 Globela Pharma
2.17.1 Business Overview
2.17.2 Gefitinib Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Globela Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.18 Jodas Expoim
2.18.1 Business Overview
2.18.2 Gefitinib Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Jodas Expoim Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.19 Nishchay Pharmaceuticals
2.19.1 Business Overview
2.19.2 Gefitinib Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Nishchay Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.20 Sichuan Xieli Pharmaceutical
2.20.1 Business Overview
2.20.2 Gefitinib Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gefitinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Gefitinib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Gefitinib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Gefitinib Manufacturer Market Share in 2018
3.3.2 Top 6 Gefitinib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Gefitinib Market Analysis by Regions
4.1 Global Gefitinib Sales, Revenue and Market Share by Regions
4.1.1 Global Gefitinib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Gefitinib Revenue and Market Share by Regions (2014-2019)
4.2 North America Gefitinib Sales and Growth Rate (2014-2019)
4.3 Europe Gefitinib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Gefitinib Sales and Growth Rate (2014-2019)
4.5 South America Gefitinib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Gefitinib Sales and Growth Rate (2014-2019)
5 North America Gefitinib by Country
5.1 North America Gefitinib Sales, Revenue and Market Share by Country
5.1.1 North America Gefitinib Sales and Market Share by Country (2014-2019)
5.1.2 North America Gefitinib Revenue and Market Share by Country (2014-2019)
5.2 United States Gefitinib Sales and Growth Rate (2014-2019)
5.3 Canada Gefitinib Sales and Growth Rate (2014-2019)
5.4 Mexico Gefitinib Sales and Growth Rate (2014-2019)
6 Europe Gefitinib by Country
6.1 Europe Gefitinib Sales, Revenue and Market Share by Country
6.1.1 Europe Gefitinib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Gefitinib Revenue and Market Share by Country (2014-2019)
6.2 Germany Gefitinib Sales and Growth Rate (2014-2019)
6.3 UK Gefitinib Sales and Growth Rate (2014-2019)
6.4 France Gefitinib Sales and Growth Rate (2014-2019)
6.5 Russia Gefitinib Sales and Growth Rate (2014-2019)
6.6 Italy Gefitinib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Gefitinib by Country
7.1 Asia-Pacific Gefitinib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Gefitinib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Gefitinib Revenue and Market Share by Country (2014-2019)
7.2 China Gefitinib Sales and Growth Rate (2014-2019)
7.3 Japan Gefitinib Sales and Growth Rate (2014-2019)
7.4 Korea Gefitinib Sales and Growth Rate (2014-2019)
7.5 India Gefitinib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Gefitinib Sales and Growth Rate (2014-2019)
8 South America Gefitinib by Country
8.1 South America Gefitinib Sales, Revenue and Market Share by Country
8.1.1 South America Gefitinib Sales and Market Share by Country (2014-2019)
8.1.2 South America Gefitinib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Gefitinib Sales and Growth Rate (2014-2019)
8.3 Argentina Gefitinib Sales and Growth Rate (2014-2019)
8.4 Colombia Gefitinib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Gefitinib by Countries
9.1 Middle East and Africa Gefitinib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Gefitinib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Gefitinib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Gefitinib Sales and Growth Rate (2014-2019)
9.3 Turkey Gefitinib Sales and Growth Rate (2014-2019)
9.4 Egypt Gefitinib Sales and Growth Rate (2014-2019)
9.5 Nigeria Gefitinib Sales and Growth Rate (2014-2019)
9.6 South Africa Gefitinib Sales and Growth Rate (2014-2019)
10 Global Gefitinib Market Segment by Type
10.1 Global Gefitinib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Gefitinib Sales and Market Share by Type (2014-2019)
10.1.2 Global Gefitinib Revenue and Market Share by Type (2014-2019)
10.2 10 Tables/Box Sales Growth and Price
10.2.1 Global 10 Tables/Box Sales Growth (2014-2019)
10.2.2 Global 10 Tables/Box Price (2014-2019)
10.3 30 Tables/Box Sales Growth and Price
10.3.1 Global 30 Tables/Box Sales Growth (2014-2019)
10.3.2 Global 30 Tables/Box Price (2014-2019)
10.4 90 Tables/Box Sales Growth and Price
10.4.1 Global 90 Tables/Box Sales Growth (2014-2019)
10.4.2 Global 90 Tables/Box Price (2014-2019)
11 Global Gefitinib Market Segment by Application
11.1 Global Gefitinib Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Gefitinib Market Forecast (2019-2024)
12.1 Global Gefitinib Sales, Revenue and Growth Rate (2019-2024)
12.2 Gefitinib Market Forecast by Regions (2019-2024)
12.2.1 North America Gefitinib Market Forecast (2019-2024)
12.2.2 Europe Gefitinib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Gefitinib Market Forecast (2019-2024)
12.2.4 South America Gefitinib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Gefitinib Market Forecast (2019-2024)
12.3 Gefitinib Market Forecast by Type (2019-2024)
12.3.1 Global Gefitinib Sales Forecast by Type (2019-2024)
12.3.2 Global Gefitinib Market Share Forecast by Type (2019-2024)
12.4 Gefitinib Market Forecast by Application (2019-2024)
12.4.1 Global Gefitinib Sales Forecast by Application (2019-2024)
12.4.2 Global Gefitinib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Gefitinib Picture
Table Product Specifications of Gefitinib
Figure Global Sales Market Share of Gefitinib by Types in 2018
Table Gefitinib Types for Major Manufacturers
Figure 10 Tables/Box Picture
Figure 30 Tables/Box Picture
Figure 90 Tables/Box Picture
Figure Gefitinib Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure France Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure China Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure India Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Gefitinib Revenue (Value) and Growth Rate (2014-2024)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Gefitinib Type and Applications
Table AstraZeneca Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Gefitinib Type and Applications
Table Qilu Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Gefitinib Type and Applications
Table Natco Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Celon Laboratories Basic Information, Manufacturing Base and Competitors
Table Celon Laboratories Gefitinib Type and Applications
Table Celon Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Gefitinib Type and Applications
Table Hetero Drugs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr Reddy's Laboratories Gefitinib Type and Applications
Table Dr Reddy's Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zuventus Healthcare Basic Information, Manufacturing Base and Competitors
Table Zuventus Healthcare Gefitinib Type and Applications
Table Zuventus Healthcare Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table United Biotech Basic Information, Manufacturing Base and Competitors
Table United Biotech Gefitinib Type and Applications
Table United Biotech Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table Panacea Biotec Gefitinib Type and Applications
Table Panacea Biotec Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Gefitinib Type and Applications
Table Cipla Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceuticals Gefitinib Type and Applications
Table Glenmark Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nobel Ilac Sanayii Ve Ticaret Basic Information, Manufacturing Base and Competitors
Table Nobel Ilac Sanayii Ve Ticaret Gefitinib Type and Applications
Table Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Accure Labs Basic Information, Manufacturing Base and Competitors
Table Accure Labs Gefitinib Type and Applications
Table Accure Labs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Gefitinib Type and Applications
Table Cadila Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Ethypharm Basic Information, Manufacturing Base and Competitors
Table Ethypharm Gefitinib Type and Applications
Table Ethypharm Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Flagship Biotech International Basic Information, Manufacturing Base and Competitors
Table Flagship Biotech International Gefitinib Type and Applications
Table Flagship Biotech International Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Globela Pharma Basic Information, Manufacturing Base and Competitors
Table Globela Pharma Gefitinib Type and Applications
Table Globela Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Jodas Expoim Basic Information, Manufacturing Base and Competitors
Table Jodas Expoim Gefitinib Type and Applications
Table Jodas Expoim Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nishchay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Nishchay Pharmaceuticals Gefitinib Type and Applications
Table Nishchay Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sichuan Xieli Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sichuan Xieli Pharmaceutical Gefitinib Type and Applications
Table Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gefitinib Sales by Manufacturer (2017-2018)
Figure Global Gefitinib Sales Market Share by Manufacturer in 2017
Figure Global Gefitinib Sales Market Share by Manufacturer in 2018
Table Global Gefitinib Revenue by Manufacturer (2017-2018)
Figure Global Gefitinib Revenue Market Share by Manufacturer in 2017
Figure Global Gefitinib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Gefitinib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Gefitinib Manufacturer (Revenue) Market Share in 2018
Figure Global Gefitinib Sales and Growth Rate (2014-2019)
Figure Global Gefitinib Revenue and Growth Rate (2014-2019)
Table Global Gefitinib Sales by Regions (2014-2019)
Table Global Gefitinib Sales Market Share by Regions (2014-2019)
Table Global Gefitinib Revenue by Regions (2014-2019)
Figure Global Gefitinib Revenue Market Share by Regions (2014-2019)
Figure Global Gefitinib Revenue Market Share by Regions in 2018
Figure North America Gefitinib Sales and Growth Rate (2014-2019)
Figure Europe Gefitinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Gefitinib Sales and Growth Rate (2014-2019)
Figure South America Gefitinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Gefitinib Sales and Growth Rate (2014-2019)
Figure North America Gefitinib Revenue and Growth Rate (2014-2019)
Table North America Gefitinib Sales by Countries (2014-2019)
Table North America Gefitinib Sales Market Share by Countries (2014-2019)
Figure North America Gefitinib Sales Market Share by Countries (2014-2019)
Figure North America Gefitinib Sales Market Share by Countries in 2018
Table North America Gefitinib Revenue by Countries (2014-2019)
Table North America Gefitinib Revenue Market Share by Countries (2014-2019)
Figure North America Gefitinib Revenue Market Share by Countries (2014-2019)
Figure North America Gefitinib Revenue Market Share by Countries in 2018
Figure United States Gefitinib Sales and Growth Rate (2014-2019)
Figure Canada Gefitinib Sales and Growth Rate (2014-2019)
Figure Mexico Gefitinib Sales and Growth Rate (2014-2019)
Figure Europe Gefitinib Revenue and Growth Rate (2014-2019)
Table Europe Gefitinib Sales by Countries (2014-2019)
Table Europe Gefitinib Sales Market Share by Countries (2014-2019)
Table Europe Gefitinib Revenue by Countries (2014-2019)
Figure Europe Gefitinib Revenue Market Share by Countries (2014-2019)
Figure Europe Gefitinib Revenue Market Share by Countries in 2018
Figure Germany Gefitinib Sales and Growth Rate (2014-2019)
Figure UK Gefitinib Sales and Growth Rate (2014-2019)
Figure France Gefitinib Sales and Growth Rate (2014-2019)
Figure Russia Gefitinib Sales and Growth Rate (2014-2019)
Figure Italy Gefitinib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Gefitinib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gefitinib Sales by Countries (2014-2019)
Table Asia-Pacific Gefitinib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Gefitinib Sales Market Share by Countries 2018
Table Asia-Pacific Gefitinib Revenue by Countries (2014-2019)
Figure Asia-Pacific Gefitinib Revenue Market Share by Countries 2018
Figure China Gefitinib Sales and Growth Rate (2014-2019)
Figure Japan Gefitinib Sales and Growth Rate (2014-2019)
Figure Korea Gefitinib Sales and Growth Rate (2014-2019)
Figure India Gefitinib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Gefitinib Sales and Growth Rate (2014-2019)
Figure South America Gefitinib Revenue and Growth Rate (2014-2019)
Table South America Gefitinib Sales by Countries (2014-2019)
Table South America Gefitinib Sales Market Share by Countries (2014-2019)
Figure South America Gefitinib Sales Market Share by Countries in 2018
Table South America Gefitinib Revenue by Countries (2014-2019)
Table South America Gefitinib Revenue Market Share by Countries (2014-2019)
Figure South America Gefitinib Revenue Market Share by Countries in 2018
Figure Brazil Gefitinib Sales and Growth Rate (2014-2019)
Figure Argentina Gefitinib Sales and Growth Rate (2014-2019)
Figure Colombia Gefitinib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Gefitinib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gefitinib Sales by Countries (2014-2019)
Table Middle East and Africa Gefitinib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Gefitinib Sales Market Share by Countries in 2018
Table Middle East and Africa Gefitinib Revenue by Countries (2014-2019)
Table Middle East and Africa Gefitinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gefitinib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gefitinib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gefitinib Sales and Growth Rate (2014-2019)
Figure UAE Gefitinib Sales and Growth Rate (2014-2019)
Figure Egypt Gefitinib Sales and Growth Rate (2014-2019)
Figure Nigeria Gefitinib Sales and Growth Rate (2014-2019)
Figure South Africa Gefitinib Sales and Growth Rate (2014-2019)
Table Global Gefitinib Sales by Type (2014-2019)
Table Global Gefitinib Sales Share by Type (2014-2019)
Table Global Gefitinib Revenue by Type (2014-2019)
Table Global Gefitinib Revenue Share by Type (2014-2019)
Figure Global 10 Tables/Box Sales Growth (2014-2019)
Figure Global 10 Tables/Box Price (2014-2019)
Figure Global 30 Tables/Box Sales Growth (2014-2019)
Figure Global 30 Tables/Box Price (2014-2019)
Figure Global 90 Tables/Box Sales Growth (2014-2019)
Figure Global 90 Tables/Box Price (2014-2019)
Table Global Gefitinib Sales by Application (2014-2019)
Table Global Gefitinib Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Gefitinib Sales, Revenue and Growth Rate (2019-2024)
Table Global Gefitinib Sales Forecast by Regions (2019-2024)
Table Global Gefitinib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Gefitinib Market Forecast (2019-2024)
Figure Europe Sales Gefitinib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Gefitinib Market Forecast (2019-2024)
Figure South America Sales Gefitinib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Gefitinib Market Forecast (2019-2024)
Table Global Gefitinib Sales Forecast by Type (2019-2024)
Table Global Gefitinib Market Share Forecast by Type (2019-2024)
Table Global Gefitinib Sales Forecast by Application (2019-2024)
Table Global Gefitinib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…- ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…
- エファビレンツ/テノホビル/エムトリシタビン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Efavirenz/Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report foc…
- 甲状腺ホルモン障害薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Thyroid Hormone Disorder Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Thyroid Hormone Dis…
- テノホビル/エムトリシタビン配合剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Tenofovir/Emtricitabine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th…